THERAPEUTIC COMPOSITIONS COMPRISING A 6 alpha ; 9 alpha -DIFLUORO-11 beta ,17 alpha ,21-TRIHYDROXY-16 alpha -METHYL-1,4-PREGNADIENE-3,20-DIONE AND 21-ACYLATES

摘要

This invention relates to therapeutic compositions and more particularly to therapeutic compositions comprising a 6 alpha ,9 alpha -difluoro-11 beta ,17 alpha ,21-trihydroxy-16 alpha -methyl-1,4-pregnadiene-3,20-dione and 21-acylates and water-ssoluble salts thereof as an essential active ingredient in combination with a pharmaceutical vehicle.